Doximity (NASDAQ:DOCS) Price Target Lowered to $49.00 at Morgan Stanley

Doximity (NASDAQ:DOCS) had its target price decreased by investment analysts at Morgan Stanley from $65.00 to $49.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s target price would suggest a potential upside of 47.15% from the company’s current price.

Several other analysts also recently commented on DOCS. Mizuho set a $45.00 target price on shares of Doximity in a research report on Wednesday. BMO Capital Markets started coverage on Doximity in a research note on Thursday, November 13th. They set a “market perform” rating and a $55.00 target price for the company. Piper Sandler reduced their price target on shares of Doximity from $70.00 to $40.00 and set an “overweight” rating for the company in a report on Friday. Truist Financial decreased their price objective on Doximity from $62.00 to $37.00 and set a “buy” rating on the stock in a report on Friday. Finally, Needham & Company LLC decreased their target price on shares of Doximity from $75.00 to $55.00 and set a “buy” rating on the stock in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Doximity has a consensus rating of “Moderate Buy” and an average price target of $57.47.

Doximity Stock Down 5.5%

DOCS opened at $33.30 on Friday. Doximity has a fifty-two week low of $32.66 and a fifty-two week high of $85.21. The firm has a market cap of $6.27 billion, a PE ratio of 33.30, a P/E/G ratio of 4.10 and a beta of 1.39. The business has a fifty day simple moving average of $43.16 and a 200-day simple moving average of $56.92.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, February 5th. The company reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period last year, the business posted $0.45 earnings per share. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. On average, equities research analysts anticipate that Doximity will post 0.99 EPS for the current fiscal year.

Doximity announced that its Board of Directors has approved a share repurchase program on Thursday, February 5th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 8% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

Hedge Funds Weigh In On Doximity

Large investors have recently modified their holdings of the stock. Voya Investment Management LLC raised its position in Doximity by 932.8% in the 3rd quarter. Voya Investment Management LLC now owns 1,567,668 shares of the company’s stock worth $114,267,000 after purchasing an additional 1,415,882 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Doximity by 325,436.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company’s stock valued at $57,515,000 after acquiring an additional 1,298,492 shares during the period. Franklin Resources Inc. boosted its holdings in Doximity by 53.9% in the second quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock valued at $193,993,000 after acquiring an additional 1,108,162 shares during the last quarter. Capital World Investors increased its position in Doximity by 25.7% in the third quarter. Capital World Investors now owns 5,381,431 shares of the company’s stock worth $393,652,000 after purchasing an additional 1,101,848 shares during the period. Finally, Victory Capital Management Inc. raised its holdings in Doximity by 525.3% during the 3rd quarter. Victory Capital Management Inc. now owns 1,096,965 shares of the company’s stock worth $80,243,000 after purchasing an additional 921,533 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity News Summary

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity announced a $500 million share buyback authorization (about 8% of shares outstanding), a signal the board views the stock as undervalued and a potential support for the equity over time. RTT News
• Positive Sentiment: Operational engagement metrics were highlighted as strong: record workflow-product adoption (720,000 users QoQ jump) and 1M+ quarterly active prescribers; early AI products show user traction — positive for long‑term monetization. Business Wire
• Positive Sentiment: Doximity was ranked #1 Best in KLAS Telehealth Video Platform for the fifth consecutive year — supportive for competitive positioning in telehealth workflows. 01net
• Neutral Sentiment: Q3 results: revenue $185.05M (+~10% YoY) and EPS $0.46, both slightly above consensus — beats were modest rather than transformative. Analysts are digging into key metrics for guidance implications. Benzinga
• Neutral Sentiment: A full earnings/management transcript is available for deeper read on product cadence, sales dynamics, and AI roadmap for investors wanting color beyond the headlines. Seeking Alpha transcript
• Negative Sentiment: Management lowered Q4 and FY2026 revenue guidance: Q4 $143.0M–$144.0M vs. consensus ~$150.2M and FY revenue guided slightly below consensus (~$642.5M–$643.5M vs. ~$645.3M). The softer outlook was the primary catalyst for a sharp after‑hours selloff. Business Wire guidance
• Negative Sentiment: Market reaction: shares plunged heavily after the print and guidance miss, reflecting investor sensitivity to near‑term growth deceleration despite buyback and solid engagement metrics. MSN market coverage

About Doximity

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.